Charles River Laboratories International Inc

CRL: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
kZ^LOCK|R<&LOCK|D?<h&Wy

Charles River Earnings: Improving Demand Environment Supports Stronger Near-Term Outlook

Charles River reported second-quarter revenue of $1 billion, a decline of 2.7% from the prior year. Management now anticipates 2026 revenue will decline 3% at the midpoint, an improvement from its previous outlook of negative 4.75%.

Sponsor Center